EMvision Medical Devices : Change of Director's Interest Notices x5

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	EMvision Medical Devices Ltd
ABN	38 620 388 230
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director		Mr Geoff Pocock
Date of last notice		3 December 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Direct or indirect interest	Indirect
	Nature of indirect interest	FAMILY A/C> - Controller of trustee and
	Note: Provide details of the circumstances giving rise to the relevant
	(including r g stered holder)	OOFY PROSSER PTY LTD <>
	Date of change	beneficiary of trust
	interest.	22 December 2021
		FAMILY A/C>
	No. of securities held prior to change	OOFY PROSSER PTY LTD <>
		355,000 ordinary shares (EMV)
		500,000 unlisted options, exercise price
		35c, expiry date 31 Dec 2021
	Class	Ordinary shares & options
	Number acquired	500,000 ordinary shares
	Number disposed	500,000 exercised options
	Note: If consideration is non-cash, provide details and estimated	$175,000
	Value/Considerat on
	valuation
	+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

	FAMILY A/C>
No. of securities held after change	OOFY PROSSER PTY LTD <>
	855,000 ordinary shares (EMV)
Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue	Exercise of options
of securities under dividend reinvestment plan, participation in buy-
back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Detail of contract	N/A
	Nature of interest	N/A
	Name of registered holder	N/A
	(if issued securities)
	Date of change	N/A
	No. and class of securities to which	N/A
	Note: Details are only required for a contract in
	interest related prior to change
	relation to which the interest has changed	N/A
	Interest acquired
	Interest disposed	N/A
	Note:Value/ConsiderationIf consideration is non-cash, provide details	N/A
	and an estimated valuation	N/A
	Interest after change
	Part 3 - +Closed period
	Were the interests in the securities or contracts detailed	No
	above traded during a +closed period where prior written
	clearance was required?
	If so, was prior written clearance provided to allow the	N/A
	trade to proceed during this period?
	If prior written clearance was provided, on what date was	N/A
	this provided?
	+ See chapter 19 for defined terms.		01/01/2011
	Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	EMvision Medical Devices Ltd
ABN	38 620 388 230
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director		Mr Tony Keane
Date of last notice		13 December 2018

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

	Direct or indirect interest	Direct & Indirect
	Nature of indirect interest	GERARD KEANE	FAMILY
	Note: Provide details of the circumstances giving rise to the relevant
	(including r g stered holder)	PATRICIA KERRY KEANE & ANTHONY
	Date of change	A/C> - Trustee and beneficiary of trust
	interest.	22 December 2021
	No. of securities held prior to change	100,000 ordinary shares (EMV)
	MR ANTHONY GERARD KEANE
		PATRICIA KERRY KEANE & ANTHONY
		GERARD KEANE	FAMILY
		A/C>
		500,000 unlisted options, exercise price
		35c, expiry date 31 Dec 2021
	Class	Ordinary shares & options
	Number acquired	500,000 ordinary shares
	Number disposed	500,000 exercised options
	+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Note: If consideration is non-cash, provide details and estimated	$175,000
Value/Considerat on
valuation
No. of securities held after change	100,000 ordinary shares (EMV)
MR ANTHONY GERARD KEANE
	PATRICIA KERRY KEANE & ANTHONY
	GERARD KEANE
	A/C>
	500,000 ordinary shares (EMV)
Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue	Exercise of options
of securities under dividend reinvestment plan, participation in buy-
back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
Note: Details are only required for a contract in
interest related prior to change
relation to which the interest has changed	N/A
Interest acquired
Interest disposed	N/A
Note:Value/ConsiderationIf consideration is non-cash, provide details	N/A
and an estimated valuation	N/A
Interest after change

+ See chapter 19 for defined terms.	01/01/2011
Appendix 3Y Page 2

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Part 3 - +Closed period

Were the interests in the securities or contracts detailed	No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was	N/A
this provided?

+ See chapter 19 for defined terms.	Appendix 3Y Page 3
01/01/2011